These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35395667)

  • 1. Significance of the RBD mutations in the SARS-CoV-2 omicron: from spike opening to antibody escape and cell attachment.
    Hossen ML; Baral P; Sharma T; Gerstman B; Chapagain P
    Phys Chem Chem Phys; 2022 Apr; 24(16):9123-9129. PubMed ID: 35395667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody.
    Yin W; Xu Y; Xu P; Cao X; Wu C; Gu C; He X; Wang X; Huang S; Yuan Q; Wu K; Hu W; Huang Z; Liu J; Wang Z; Jia F; Xia K; Liu P; Wang X; Song B; Zheng J; Jiang H; Cheng X; Jiang Y; Deng SJ; Xu HE
    Science; 2022 Mar; 375(6584):1048-1053. PubMed ID: 35133176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
    Lupala CS; Ye Y; Chen H; Su XD; Liu H
    Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody.
    Lee M; Major M; Hong H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex.
    Ching WY; Adhikari P; Jawad B; Podgornik R
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape.
    Zhao Z; Zhou J; Tian M; Huang M; Liu S; Xie Y; Han P; Bai C; Han P; Zheng A; Fu L; Gao Y; Peng Q; Li Y; Chai Y; Zhang Z; Zhao X; Song H; Qi J; Wang Q; Wang P; Gao GF
    Nat Commun; 2022 Aug; 13(1):4958. PubMed ID: 36002453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical Fitness Landscape of the SARS-CoV-2 Delta Variant Receptor Binding Domain.
    Patrick C; Upadhyay V; Lucas A; Mallela KMG
    J Mol Biol; 2022 Jul; 434(13):167622. PubMed ID: 35533762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations.
    Verkhivker G; Agajanian S; Kassab R; Krishnan K
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
    Ye G; Liu B; Li F
    Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding.
    Lin S; Chen Z; Zhang X; Wen A; Yuan X; Yu C; Yang J; He B; Cao Y; Lu G
    Signal Transduct Target Ther; 2022 Feb; 7(1):56. PubMed ID: 35190526
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
    Yang TJ; Yu PY; Chang YC; Liang KH; Tso HC; Ho MR; Chen WY; Lin HT; Wu HC; Hsu SD
    Nat Struct Mol Biol; 2021 Sep; 28(9):731-739. PubMed ID: 34385690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins.
    Xu Y; Wu C; Cao X; Gu C; Liu H; Jiang M; Wang X; Yuan Q; Wu K; Liu J; Wang D; He X; Wang X; Deng SJ; Xu HE; Yin W
    Cell Res; 2022 Jul; 32(7):609-620. PubMed ID: 35641567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant.
    An K; Yang X; Luo M; Yan J; Xu P; Zhang H; Li Y; Wu S; Warshel A; Bai C
    Proteins; 2024 Jun; 92(6):705-719. PubMed ID: 38183172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.
    Javanmardi K; Segall-Shapiro TH; Chou CW; Boutz DR; Olsen RJ; Xie X; Xia H; Shi PY; Johnson CD; Annapareddy A; Weaver S; Musser JM; Ellington AD; Finkelstein IJ; Gollihar JD
    Cell Host Microbe; 2022 Sep; 30(9):1242-1254.e6. PubMed ID: 35988543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryo-EM structure of the SARS-CoV-2 Omicron spike.
    Cerutti G; Guo Y; Liu L; Liu L; Zhang Z; Luo Y; Huang Y; Wang HH; Ho DD; Sheng Z; Shapiro L
    Cell Rep; 2022 Mar; 38(9):110428. PubMed ID: 35172173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.
    Taft JM; Weber CR; Gao B; Ehling RA; Han J; Frei L; Metcalfe SW; Overath MD; Yermanos A; Kelton W; Reddy ST
    Cell; 2022 Oct; 185(21):4008-4022.e14. PubMed ID: 36150393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels.
    Alves J; Engel L; de Vasconcelos Cabral R; Rodrigues EL; de Jesus Ribeiro L; Higa LM; da Costa Ferreira Júnior O; Castiñeiras TMPP; de Carvalho Leitão I; Tanuri A; Goueli SA; Zegzouti H
    Sci Rep; 2021 Sep; 11(1):18428. PubMed ID: 34531417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.